Login / Signup

Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab.

Kiyotaka NakamagoeTakeshi YamadaSho OkuneToshikazu MoriwakiAkira Tamaoka
Published in: Acta neurologica Belgica (2021)
Keyphrases
  • advanced non small cell lung cancer
  • case report
  • adverse drug
  • drug induced
  • electronic health record